Fixing Healthcare Podcast

In this Diving Deep episode, Dr. Robert Pearl and Jeremy Corr examine two very different healthcare debates that share a common problem: when medicine lacks good evidence and aligned incentives, patients and doctors are left with bad choices.

The conversation begins with experimental peptides, a fast-growing topic on social media and in wellness circles. Dr. Pearl reviews the FDA’s ongoing debate over whether six experimental peptides should be made available to licensed compounding pharmacies. Supporters argue that Americans are already buying these substances through the gray market, often from overseas suppliers, and that regulated access would be safer. Critics argue that expanded access would encourage far more people to use products whose benefits, risks, purity and long-term safety remain uncertain.

For Pearl, both sides are partly right, which is why a simple yes or no is the wrong answer.

Saying no would not eliminate demand. It would leave many Americans buying peptides online without reliable quality control. Saying yes without conditions would create the impression of FDA approval without the scientific evidence normally required to prove safety and efficacy. Instead, Pearl argues for a third path: pair regulated access with federally coordinated research, safety reporting and controlled studies so patients, doctors and regulators can learn whether these peptides actually work and whether they are safe.

The second half of the episode turns to primary care, a specialty Pearl says is in serious trouble.

Primary care physicians are overburdened, under-resourced and underpaid compared with specialists. They face growing patient panels, administrative demands, declining autonomy and less interest from medical students entering the field.

Pearl acknowledges that primary care leaders are right to ask for more respect, more support and better compensation. But he argues that payers are unlikely to invest substantially more unless primary care can demonstrate better outcomes and lower total costs. That has not happened consistently under traditional fee-for-service or pay-for-performance programs, which reward isolated steps in care rather than overall clinical impact.

The solution is capitation. Under this model, primary care doctors would receive a prospective payment to care for a defined population rather than being paid for each visit or service. If chronic diseases are controlled, emergency department use falls and complications decline, both patients and clinicians benefit. But capitation also requires doctors to accept financial risk, organize into larger groups, adopt common clinical standards, coordinate care and empower effective physician leaders.

The episode closes with a call for national primary care societies to lead. Pearl says they can help doctors form groups, negotiate capitated contracts, purchase stop-loss protection, implement generative AI, build clinical infrastructure and spread best practices from early demonstration programs.

Across both topics, Pearl returns to the same point. Whether the issue is experimental peptides or the future of primary care, patients need evidence, doctors need accountability and the system needs incentives that reward better health.

For more, tune into this month’s episode and check out the link below.

Helpful links:

The Best FDA Decision On Peptide Authorization Isn’t Yes Or No (Forbes)

Monthly Musings on American Healthcare (RobertPearlMD.com)

* * *

Dr. Robert Pearl is the author of ChatGPT, MD: How AI-Empowered Patients & Doctors Can Take Back Control of American Medicine.

Fixing Healthcare is a co-production of Dr. Robert Pearl and Jeremy Corr. Subscribe to the show via Apple, Spotify or wherever you find podcasts. Join the conversation or suggest a guest by following the show on X and LinkedIn.

The post FHC #226: Peptides, primary care & the false choices in American medicine appeared first on Fixing Healthcare.

In this week’s episode of Medicine: The Truth, hosts Jeremy Corr and Dr. Robert Pearl go in search of the facts beneath healthcare’s biggest headlines. Today’s show opens with one of the hottest and least understood medical topics: experimental peptides.

Pearl explains that an FDA advisory committee narrowly recommended allowing compounding pharmacies to provide six experimental peptides to patients. This is not the same as traditional FDA approval. Rather than reviewing a drug through the usual three-phase clinical trial process, the recommendation would allow suppliers to provide peptide ingredients that compounding pharmacies could use to fill prescriptions.

Pearl then explains why this distinction matters. If the FDA follows the committee’s recommendation, many patients may assume the peptides have been vetted like other approved medications. He warns that this could leave the nation in a medical gray zone, with broad access but little rigorous evidence on safety, effectiveness, dosing or long-term risk.

The episode then turns to several follow-up stories and new medical developments, including the cyclospora outbreak, CDC leadership, pediatric e-bike injuries, AI-designed viruses, Ebola, mRNA flu vaccines and the continuing politicization of vaccine policy:

The cyclospora outbreak appears to be slowing, but the total case count remains high and the exact source has not been fully confirmed.

Erica Schwartz has been confirmed as CDC director, becoming the agency’s first full-time leader in a year. Pearl says Schwartz has strong credentials but will face major challenges, including depleted agency staffing, infectious disease outbreaks and political pressure around vaccines.

Pediatric e-scooter and e-bike injuries surpassed 2,000 incidents from 2020 to 2024, according to data from Johns Hopkins researchers. Pearl warns that more states may need to restrict use among young children.

AI can design viruses that do not currently exist in nature, a new Stanford study showed. This opens possibilities for new treatments but also raising biosecurity concerns. Pearl says the technology could one day help fight antibiotic-resistant bacterial infections, but it also raises concerns about bad actors.

Ebola is spreading rapidly in the Democratic Republic of Congo, with more than 1,500 deaths and a mortality rate estimated at 40% to 50%.

The FDA approved the first mRNA flu vaccine, developed by Moderna, for adults 50 and older. Pearl explains that mRNA technology could improve flu vaccination by allowing scientists to update vaccines closer to the arrival of each year’s viral strain.

The episode closes with Pearl’s strongest warning: medical decisions made on politics rather than science lead to harm. He points to President Trump’s executive order changing childhood vaccine recommendations and encouraging separation of the MMR vaccine into individual measles, mumps and rubella shots.

Pearl says there is no scientific evidence supporting the president’s claim that the combined MMR vaccine may be dangerous, while numerous studies show it is safe, effective and lifesaving. His conclusion: when scientific evidence is overwhelming, leaders need a compelling scientific reason to deviate from it. Whether the subject is experimental peptides, AI-designed viruses, mRNA vaccines or childhood immunization, medicine cannot protect patients if politics replaces data.

Tune in to hear the full discussion and subscribe to Medicine: The Truth for more fact-based analysis of the medical, scientific and policy stories shaping American healthcare.

* * *

Dr. Robert Pearl is the author of “ChatGPT, MD: How AI-Empowered Patients & Doctors Can Take Back Control of American Medicine” about the impact of AI on the future of medicine.

Fixing Healthcare is a co-production of Dr. Robert Pearl and Jeremy Corr. Subscribe to the show via Apple, Spotify or wherever you find podcasts. Join the conversation or suggest a guest by following the show on X and LinkedIn.

The post MTT #110: Peptides, politics & the perils of medicine without evidence appeared first on Fixing Healthcare.

In this Unfiltered episode of Fixing Healthcare, Drs. Robert Pearl and Jonathan Fisher join cohost Jeremy Corr for a wide-ranging conversation about burnout, kindness, leadership, medical errors and what American healthcare can learn from other nations.

The episode begins with Fisher’s recent trip to Australia, where he joined physicians and other healthcare professionals for a program focused on individual well-being, organizational well-being and burnout. Held near Uluru, on sacred Aboriginal land, the gathering included conversations with tribal elders about the connection between land, culture, traditional remedies and healing.

Fisher explains that some Australian hospitals have incorporated Aboriginal traditions alongside Western medicine, not as a replacement for modern care, but as a way to build trust and honor patients’ cultural identity. That approach, he says, has helped Indigenous patients feel more respected by the healthcare system.

Pearl connects the discussion to a larger economic reality. Although the United States spends far more on healthcare than other nations, many countries are facing the same underlying pressure: medical costs rising faster than wages, GDP or general inflation. For clinicians, the result is familiar across borders: more work, more bureaucracy, more isolation and growing frustration.

From there, the conversation shifts to kindness in leadership. Fisher draws an important distinction between being kind and being nice. Niceness, he argues, is often about wanting people to like us or avoiding discomfort. Kindness is different. True kindness may require difficult conversations, honest feedback and decisions that create short-term discomfort but protect patients, teams and organizations over time.

That distinction leads into one of the episode’s central leadership questions: How should medical leaders respond when a physician is struggling, underperforming or causing avoidable harm?

Pearl emphasizes that leaders must keep the patient at the center. Fisher adds that fairness matters deeply, especially in how feedback is delivered. Leaders should be prompt, clear, transparent about process and respectful of the physician’s dignity.

Finally, the discussion shifts to generative AI and diagnostic errors. Pearl raises the possibility that AI tools could help identify missed diagnoses in emergency departments before patients are discharged or admitted. Fisher agrees that AI can help prevent harm, but warns that emergency physicians are already overwhelmed. A tool that produces too many alerts, even if well intended, could worsen cognitive overload and be ignored.

Jeremy closes with a patient-centered question about what both physicians have seen in other countries that they wish existed in the United States. Fisher points to the sense, in some countries with socialized medicine, that everyone deserves a basic level of care. Pearl describes a hospital visit in Sweden, where strong social supports and clinician collaboration produced better outcomes by addressing many social determinants before they reached the medical system.

For more unfiltered conversation, listen to the full episode and explore these related resources:

‘Just One Heart’ (Jonathan Fisher’s newest book)

‘ChatGPT, MD’ (Robert Pearl’s newest book)

Monthly Musings on American Healthcare (Robert Pearl’s newsletter)

* * *

Fixing Healthcare is a co-production of Dr. Robert Pearl and Jeremy Corr. Subscribe to the show via Apple Podcasts or wherever you find podcasts. Join the conversation or suggest a guest by following the show on X and LinkedIn.

The post FHC #225: Kindness, burnout and the limits of medical leadership appeared first on Fixing Healthcare.

Dr. Austin Chiang has built one of medicine’s most distinctive public platforms.

He is a triple board-certified gastroenterologist, Chief Medical Officer for Medtronic’s Endoscopy business and Associate Professor of Medicine at Thomas Jefferson University. He is also one of healthcare’s most influential physician voices online, with hundreds of thousands of followers across TikTok, Instagram, YouTube and LinkedIn.

That makes him an ideal guest for Season 11 of Fixing Healthcare with cohosts Dr. Robert Pearl and Jeremy Corr. This season asks what patients, clinicians and healthcare leaders are saying now that feels meaningfully different from the past.

Chiang hears those concerns from several vantage points: as a practicing physician, medical technology leader, educator and public-facing doctor.

For Chiang, three issues stand out:

Clinician burnout and loss of autonomy

Chiang says physicians are struggling with administrative burden, documentation demands, prior authorization, staffing shortages, reimbursement pressure and a growing sense that medical decisions are no longer fully in their hands. Pearl pushes further, asking whether clinicians must take more responsibility for affordability rather than simply objecting to the oversight created in response to rising costs. Chiang agrees that physicians need a better understanding of the broader healthcare ecosystem if they want to help change it.

Medical misinformation and social media

Chiang has spent more than a decade learning how to communicate across platforms and audiences. He explains that accurate medical information must now compete with sensationalized claims from people who are not held to the same professional standards as clinicians. For doctors, the challenge is to be credible without being boring, engaging without becoming irresponsible and platform-specific without compromising the message. That tension is especially important in areas like gut health, diet, probiotics and the microbiome, where uncertainty creates space for simple but potentially misleading answers.

Clinician-led innovation

As Medtronic’s Chief Medical Officer for Endoscopy, Chiang works at the intersection of clinical practice and medical technology. He explains that innovation in medicine is slow for good reason: new tools must prove safety, clinical value, workflow fit and real-world usefulness before becoming mainstream. But he argues that clinicians need to be more involved in that process because they understand the nuances of patient care, staff experience and adoption better than outsiders can.

The conversation also explores colorectal cancer, which is rising among younger adults. Chiang explains why colonoscopy remains the gold standard for prevention, while also noting that lowering screening ages further would create major capacity challenges. He also discusses AI-assisted polyp detection, the future of endoscopy and why fully autonomous colonoscopy remains difficult given the complexity of human anatomy.

There’s much more in this conversation, including physician career paths beyond traditional practice, how doctors should respond when patients bring AI-generated information to appointments and what people with chronic GI conditions need from clinicians, platforms and online communities.

Tune in to hear one of medicine’s most visible digital physician leaders explain how doctors can help shape a future where technology, social media and medical innovation better serve patients.

* * *

Fixing Healthcare is a co-production of Dr. Robert Pearl and Jeremy Corr. Subscribe to the show via Apple, Spotify, Stitcher or wherever you find podcasts. Join the conversation or suggest a guest by following the show on X and LinkedIn.

The post FHC #224: Austin Chiang on burnout, misinformation and the future of med-tech appeared first on Fixing Healthcare.

In this Diving Deep episode, Dr. Robert Pearl and Jeremy Corr examine two big questions facing American medicine: how generative AI can make healthcare more affordable and what the World Cup can teach doctors about strategy, teamwork and leadership.

The conversation begins with a counterintuitive point: In other industries, technology often lowers costs by allowing companies to produce the same output with fewer workers. But Dr. Pearl knows medicine is different. In healthcare, the biggest costs arise when preventable and controllable conditions turn into life-threatening complications. Therefore, he does not believe GenAI’s greatest financial value in healthcare will come from replacing doctors and nurses.

Pearl argues that the surest way to lower healthcare spending is by keeping people healthier. Poorly controlled hypertension, diabetes, heart failure and kidney disease drive many of the nation’s most expensive complications, including heart attacks, strokes, kidney failure, hospitalizations and surgeries. GenAI can help prevent those outcomes, and the savings could far exceed anything gained by reducing clinician headcount.

From there, Pearl identifies three major opportunities for GenAI-driven improvements:

Control chronic diseases by helping patients understand their conditions, track data from home devices and get medication adjustments sooner (rather than waiting months between office visits).

Expand access to medical expertise after hours and on weekends.

Improve care coordination and medication safety, especially for older adults with multiple chronic conditions.

But technology alone will not be enough. So, the second half of the episode turns to entrepreneurship and leadership. Pearl discusses new research comparing expensive physician-facing AI tools with general-purpose large language models such as ChatGPT, Claude and Gemini.

His takeaway for entrepreneurs is clear: the biggest opportunity may not be building costly tools for hospitals, but helping patients use the AI tools already available on their computers and smartphones to manage their health more effectively.

That point leads into a broader lesson from the recent World Cup. Pearl argues that American medicine, like many talented teams that failed to win soccer’s biggest prize, has extraordinary resources but lacks a shared strategy. The United States has exceptional doctors, world-class hospitals and more healthcare spending than any nation, yet outcomes remain inconsistent, access unreliable and costs unaffordable.

The episode closes with a warning and a challenge. American medicine already has the talent, technology and financial resources to succeed. What it lacks is a clear strategy, coordinated teamwork and effective clinician leadership. If doctors want to improve care for patients and preserve the profession’s values, Pearl argues, they will need to embrace new technology, work together differently and take responsibility for the system’s performance.

For more, tune into this month’s episode and check out the links below.

Helpful links:

Entrepreneurs Beware: Inexpensive AI Is The Future Of Medicine (Forbes)

GenAI Won’t Lower Medical Costs By Replacing Doctors And Nurses (Forbes)

47 World Cup Teams Fell Short. US Medicine Should Learn From Them (Forbes)

Monthly Musings on American Healthcare (RobertPearlMD.com)

* * *

Dr. Robert Pearl is the author of ChatGPT, MD: How AI-Empowered Patients & Doctors Can Take Back Control of American Medicine.

Fixing Healthcare is a co-production of Dr. Robert Pearl and Jeremy Corr. Subscribe to the show via Apple, Spotify or wherever you find podcasts. Join the conversation or suggest a guest by following the show on X and LinkedIn.

The post FHC #223: How GenAI & World Cup strategy can help fix healthcare appeared first on Fixing Healthcare.